ID
35832
Description
Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (SADAL); ODM derived from: https://clinicaltrials.gov/show/NCT02227251
Link
https://clinicaltrials.gov/show/NCT02227251
Keywords
Versions (1)
- 3/26/19 3/26/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
March 26, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diffuse Large B-cell Lymphoma NCT02227251
Eligibility Diffuse Large B-cell Lymphoma NCT02227251
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Diffuse Large B-Cell Lymphoma | Histology Other
Data type
boolean
Alias
- UMLS CUI [1]
- C0079744
- UMLS CUI [2,1]
- C0344441
- UMLS CUI [2,2]
- C0205394
Description
Therapy High dose Autologous Stem Cell Rescue
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0444956
- UMLS CUI [1,3]
- C2825926
Description
Mediastinal (Thymic) Large B-Cell Lymphoma
Data type
boolean
Alias
- UMLS CUI [1]
- C1292754
Description
Central nervous system lymphoma
Data type
boolean
Alias
- UMLS CUI [1]
- C0742472
Description
Hepatitis B | Hepatitis C
Data type
boolean
Alias
- UMLS CUI [1]
- C0019163
- UMLS CUI [2]
- C0019196
Description
HIV Infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0019693
Description
Lacking Able to swallow Tablets | Malabsorption Syndrome | Gastrointestinal Disease Interferes with Absorption Investigational New Drugs | Gastrointestinal function Interferes with Absorption Investigational New Drugs
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0332268
- UMLS CUI [1,2]
- C2712086
- UMLS CUI [1,3]
- C0039225
- UMLS CUI [2]
- C0024523
- UMLS CUI [3,1]
- C0017178
- UMLS CUI [3,2]
- C0521102
- UMLS CUI [3,3]
- C0237442
- UMLS CUI [3,4]
- C0013230
- UMLS CUI [4,1]
- C0516983
- UMLS CUI [4,2]
- C0521102
- UMLS CUI [4,3]
- C0237442
- UMLS CUI [4,4]
- C0013230
Similar models
Eligibility Diffuse Large B-cell Lymphoma NCT02227251
- StudyEvent: Eligibility
C1515568 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C0079744 (UMLS CUI [1,3])
C0344441 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0444956 (UMLS CUI [1,2])
C2825926 (UMLS CUI [1,3])
C0019196 (UMLS CUI [2])
C2712086 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,3])
C0024523 (UMLS CUI [2])
C0017178 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0237442 (UMLS CUI [3,3])
C0013230 (UMLS CUI [3,4])
C0516983 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0237442 (UMLS CUI [4,3])
C0013230 (UMLS CUI [4,4])